32 Neuro-endocriene tumoren

go back to reference 1 Caplin ME, Buscombe JR, Hilson AJ, et al. Carcinoid tumour. Lancet 1998:352(9130):799-805.CrossRef 1 Caplin ME, Buscombe JR, Hilson AJ, et al. Carcinoid tumour. Lancet 1998:352(9130):799-805.CrossRef

go back to reference 2 Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg 1994;178:187-211. 2 Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg 1994;178:187-211.

go back to reference 3 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg 2011 Mar;396(3):299-311.CrossRef 3 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg 2011 Mar;396(3):299-311.CrossRef

go back to reference 4 Knechtle SJ, Kalayoglu M, D’Alessandro AM, et al. Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. Am Surg 1997;225:345-6. 4 Knechtle SJ, Kalayoglu M, D’Alessandro AM, et al. Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. Am Surg 1997;225:345-6.

go back to reference 5 Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E, Pingpank J, Oberg K, Cohen SJ, Posner MC, Yao JC. Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol 2011 Mar 1;29(7):934-43.CrossRef 5 Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E, Pingpank J, Oberg K, Cohen SJ, Posner MC, Yao JC. Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol 2011 Mar 1;29(7):934-43.CrossRef

go back to reference 6 Kvols LK, Moertel CG, O’Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. New Eng J Med 1986;315:663-6.CrossRef 6 Kvols LK, Moertel CG, O’Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. New Eng J Med 1986;315:663-6.CrossRef

go back to reference 7 Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. New Engl J Med 1990;323(18):1246-9.CrossRef 7 Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. New Engl J Med 1990;323(18):1246-9.CrossRef

go back to reference 8 Modlin IM, Oberg K, Chung DC, Jensen RT, Herder WW de, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008 Jan;9(1):61-72.CrossRef 8 Modlin IM, Oberg K, Chung DC, Jensen RT, Herder WW de, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008 Jan;9(1):61-72.CrossRef

go back to reference 9 Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.CrossRef 9 Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.CrossRef

go back to reference 10 Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997;112:583-90.CrossRef 10 Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997;112:583-90.CrossRef

go back to reference 11 Moertel CG. Karnofsky memorial lecture. An odyssee in the land of small tumors. J Clin Oncol 1987;5:1502-22. 11 Moertel CG. Karnofsky memorial lecture. An odyssee in the land of small tumors. J Clin Oncol 1987;5:1502-22.

go back to reference 12 Mozell E, Stenzel P, Weltering EA, et al. Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment. Curr Probl Surg 1990;27:301-86. 12 Mozell E, Stenzel P, Weltering EA, et al. Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment. Curr Probl Surg 1990;27:301-86.

go back to reference 13 Oberg K. Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin Oncol 1998;10:58-65. 13 Oberg K. Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin Oncol 1998;10:58-65.

go back to reference 14 Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab 1980;9:211-22. 14 Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab 1980;9:211-22.

go back to reference 15 Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. New Engl J Med 2011 Feb 10;364(6):501-13. 15 Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. New Engl J Med 2011 Feb 10;364(6):501-13.

go back to reference 16 Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, Herder WW de, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B; and all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006 Oct;449(4):395-401. 16 Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, Herder WW de, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B; and all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006 Oct;449(4):395-401.

go back to reference 17 Solcia E, Klöppel G, Sobin LH. 2000 Histological typing of endocrine tumours. 2nd ed. World Health Organization International Histological Classification of Tumours. Berlijn: Springer. 17 Solcia E, Klöppel G, Sobin LH. 2000 Histological typing of endocrine tumours. 2nd ed. World Health Organization International Histological Classification of Tumours. Berlijn: Springer.

go back to reference 18 Thompson GB, Heerden JA van, Grant CS, et al. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988;104:1011-7. 18 Thompson GB, Heerden JA van, Grant CS, et al. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988;104:1011-7.

go back to reference 19 Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, Vries EG de, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K; RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors. New Engl J Med 2011 Feb 10;364(6):514-23. 19 Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, Vries EG de, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K; RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors. New Engl J Med 2011 Feb 10;364(6):514-23.